Day after day, our Customers & Partners are progressing to develop new therapies with Dendrigraft of L-Lysine from proof of concept at lab scale up to clinical trial in:
- Targeting Drug/Gene Delivery
- CNS Targeting
- MRI Contrast Agent for Medical Imaging
- Cell Culture
- In Vivo Antibody Production
- Growth Factors Controlled Release
More than 90 scientific publications about COLCOM's DGL are now available on our website.